Targeting FcRn for the modulation of antibody dynamics
Targeting FcRn for the modulation of antibody dynamics
The MHC class I-related receptor, FcRn, is a multitasking protein that transports its IgG ligand within and across cells of diverse origins. The role of this receptor as a global regulator of IgG homeostasis and transport, combined with knowledge of the molecular details of FcRn-IgG interactions, has led to opportunities to modulate the in vivo dynamics of antibodies and their antigens through protein engineering. Consequently, the generation of half-life extended antibodies has shown a rapid expansion over the past decade. Further, FcRn itself can be targeted by inhibitors to induce decreased levels of circulating IgGs, which could have applications in multiple clinical settings. The engineering of antibody-antigen interactions to reduce antibody-mediated buffering of soluble ligand has also developed into an active area of investigation, leading to novel antibody platforms designed to result in more effective antigen clearance. Similarly, the target-mediated elimination of antibodies by internalizing, membrane bound antigens (receptors) can be decreased using novel engineering approaches. These strategies, combined with subcellular trafficking analyses of antibody/antigen/FcRn behavior in cells to predict in vivo behavior, have considerable promise for the production of next generation therapeutics and diagnostics.
Antibody engineering, FcRn, IgG, PH-dependence, Pharmacokinetics, Therapeutic antibodies
131-141
Ward, E. Sally
b31c0877-8abe-485f-b800-244a9d3cd6cc
Devanaboyina, Siva Charan
4a79edaf-305f-4413-88b2-946e6284f98e
Ober, Raimund J.
31f4d47f-fb49-44f5-8ff6-87fc4aff3d36
1 October 2015
Ward, E. Sally
b31c0877-8abe-485f-b800-244a9d3cd6cc
Devanaboyina, Siva Charan
4a79edaf-305f-4413-88b2-946e6284f98e
Ober, Raimund J.
31f4d47f-fb49-44f5-8ff6-87fc4aff3d36
Ward, E. Sally, Devanaboyina, Siva Charan and Ober, Raimund J.
(2015)
Targeting FcRn for the modulation of antibody dynamics.
Molecular Immunology, 67 (2), .
(doi:10.1016/j.molimm.2015.02.007).
Abstract
The MHC class I-related receptor, FcRn, is a multitasking protein that transports its IgG ligand within and across cells of diverse origins. The role of this receptor as a global regulator of IgG homeostasis and transport, combined with knowledge of the molecular details of FcRn-IgG interactions, has led to opportunities to modulate the in vivo dynamics of antibodies and their antigens through protein engineering. Consequently, the generation of half-life extended antibodies has shown a rapid expansion over the past decade. Further, FcRn itself can be targeted by inhibitors to induce decreased levels of circulating IgGs, which could have applications in multiple clinical settings. The engineering of antibody-antigen interactions to reduce antibody-mediated buffering of soluble ligand has also developed into an active area of investigation, leading to novel antibody platforms designed to result in more effective antigen clearance. Similarly, the target-mediated elimination of antibodies by internalizing, membrane bound antigens (receptors) can be decreased using novel engineering approaches. These strategies, combined with subcellular trafficking analyses of antibody/antigen/FcRn behavior in cells to predict in vivo behavior, have considerable promise for the production of next generation therapeutics and diagnostics.
This record has no associated files available for download.
More information
Accepted/In Press date: 6 February 2015
e-pub ahead of print date: 9 March 2015
Published date: 1 October 2015
Keywords:
Antibody engineering, FcRn, IgG, PH-dependence, Pharmacokinetics, Therapeutic antibodies
Identifiers
Local EPrints ID: 423661
URI: http://eprints.soton.ac.uk/id/eprint/423661
ISSN: 0161-5890
PURE UUID: ad612042-3716-4d3b-a94e-f7f557698ed6
Catalogue record
Date deposited: 27 Sep 2018 16:30
Last modified: 18 Mar 2024 03:48
Export record
Altmetrics
Contributors
Author:
Siva Charan Devanaboyina
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics